Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
|
|
IDEAYA Biosciences, Inc. (IDYA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2021 |
8-K
| Quarterly results |
| 06/16/2020 |
8-K
| Investor presentation |
| 01/13/2020 |
8-K
| Investor presentation |
| 11/13/2019 |
8-K
| Quarterly results |
| 08/12/2019 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"IDEAYA Biosciences, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update South San Francisco, CA, August 12, 2019 - IDEAYA Biosciences, Inc. , an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, provided a business update and announced financial results for the second quarter ended June 30, 2019. “The initiation of our Phase 1/2 basket trial evaluating IDE196 in patients with solid tumors harboring GNAQ/11 mutations is an important step in the clinical development of IDE196. We are identifying and enrolling patients with solid tumors having likely pathogenic GNAQ/11 hotspot mutations that activate the PKC signaling pathway. We believe this ...",
"Investor Presentation of IDEAYA Biosciences, Inc" |
|
|
|